CN1928117A - Method of synchronous distinguishing newcastle disease virus and vaccine virus and identifying virulence and genotype - Google Patents

Method of synchronous distinguishing newcastle disease virus and vaccine virus and identifying virulence and genotype Download PDF

Info

Publication number
CN1928117A
CN1928117A CN 200510060646 CN200510060646A CN1928117A CN 1928117 A CN1928117 A CN 1928117A CN 200510060646 CN200510060646 CN 200510060646 CN 200510060646 A CN200510060646 A CN 200510060646A CN 1928117 A CN1928117 A CN 1928117A
Authority
CN
China
Prior art keywords
virus
vaccine
sequence
newcastle disease
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200510060646
Other languages
Chinese (zh)
Inventor
单松华
邵朝纲
徐秀芳
徐朝哲
张念慈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huzhou University
Original Assignee
Huzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huzhou University filed Critical Huzhou University
Priority to CN 200510060646 priority Critical patent/CN1928117A/en
Publication of CN1928117A publication Critical patent/CN1928117A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention discloses molecular biological method and automatic analysis software for distinguishing wild virus strain and vaccine virus strain of new castle disease virus (NDV), and identifying the toxicity and genotype simultaneously. The NDV is RT-PCR amplified with one pair of specific degenerate primers to obtain one multipurpose NDV segment for direct sequencing of the PCR product. One automatic analysis software is composed for comparing the homology of the sequence to the standard vaccine sequence so as to distinguish wild virus strain and vaccine virus strain, analyze the toxicity by means of the F gene cracking site and judge the genotype through developing tree analysis. The present invention has short detecting period, reliable detection result and capacity of obtaining several detection results simultaneously, and is suitable for use in fowl product inspector and quarantiner.

Description

Synchronous distinguishing newcastle disease virus and vaccine virus are identified virulence and genotypic method
Technical field
The present invention relates to a kind of energy synchronous distinguishing newcastle disease virus and vaccine virus, identify its virulence and genotypic molecular biology method and supporting automated analysis software thereof.
Background technology
Newcastle disease (ND) is a kind of deadly infectious disease of bird.Because its propagation is rapid, popular extensively, M ﹠ M is high, cause the aviculture loss serious, and the country of outburst newcastle disease, its bird product international trade is forbidden and is limited, caused the bigger loss of aviculture.International Office of Epizootics classifies it as category-A transmissible disease, and China classifies it as class epidemic prevention object, and the inspection and quarantine system classifies it class Quarantine Objects of port quarantine as.
New city eqpidemic disease (ND) is a kind of acute infectious disease that is caused by Avian pneumo-encephalitis virus (NDV), and nineteen twenty-six is broken out first in the new city of Indonesia and Britain, so name Avian pneumo-encephalitis virus (Alexander DJ, 1982).It belongs to Paramyxoviridae (Paramyxoviridae), the member of Rubulavirus (Rubulavirus) family (Rima BK et al., 1995).Genome is a sub-thread strand RNA, comprises about 15kb base, and six albumen: 3 '-NP-P-M-F-HN-L-5 ' encode.
According to the seriousness difference of the caused clinical symptom of infection ability and infection back, NDV can be divided into strong poison (velogenic), poison (mesogenic) and weak poison (lentogenic) three classes (AlexanderD J, 1997).NDV virulent strain infectivity is very strong, usually to cause that lytic infection is feature; And the infectivity of NDV low virulent strain and virulence are very weak, generally do not have the acute infection illness, in fact, comprise a little less than many strains of La Sota etc. malicious NDV usually on producing by with the malicious vaccine of laboring.
F albumen is the main factor (Chen L et al., 2001) that merges viral lipoprotein cyst membrane and host cell surface coating, is the main determining factor (Glickman et al., 1988) of virus virulence.F albumen is at first with inertia precursor F 0Form synthetic, in the virus multiplication process, produce the F that connects by disulfide linkage through the host cell proteins enzymic hydrolysis 1-F 2Two segment (NH 2-F 2-S-S-F 1-COOH) after, show fusion-activity, thereby make virus have infectivity.Cracking site is positioned at the 112-117 amino acids, and it is the key of decision cracking ability that its amino acid is formed, thereby also is the key that influences virus virulence.Consisting of of virulent strain cracking zone domain amino acid 112R/K-R-Q-K/R-R-F 117, promptly two pairs of basic aminoacidss that separated by Q are formed, so the cracking site of virulent strain is easy to be discerned and cracking by ubiquitous host protein lytic enzyme furin.Low virulent strain then is 112G/E-K/R-Q-G/E-R-L 117, be difficult for identification, so cracking do not take place in low virulent strain in most cells by host protein lytic enzyme furin, and with nonactive precursor F 0Proteic form is delivered to filial generation, and infection activity reduces or forfeiture.This is the amino acid composition in F gene cracking site district and the molecular basis of the strong and weak dependency of NDV virulence.Li Z etc. (1998) are (2002) such as the analysis of basis reorganization NDV virus and Yu with the low virulent strain to the point mutation analysis of shearing site and Peeters (1999) etc. provides direct evidence to the analysis of the shearing site of virulence transition type street strain for this reason.But this is not whole factors of virulence decision, HN albumen yet relevant with virus virulence (Toyoda et al., 1989).
According to the difference of F gene order, the phylogeny of NDV is analyzed, can be divided into I-VII totally 7 genotype (Shan SH et al., 2003 to NDV; Liu XF et al., 2003), this has disclosed the epidemiological features of NDV on molecular level.
Newcastle disease is still one of poultry diease that China's distribution is the widest, harm is the most serious at present, and the best way of control ND is vaccination.In the production, in, the general deactivation of strong toxic vaccine strain is used, and uses with the malicious form of living the toxic vaccine strain (as poisoning vaccine I system) in weak poison (as La Sota) and the part.The malicious vaccine of living uses upward more convenient; And the immune protective effect that the inactivated vaccine and the malicious vaccine mixing of living are used is better.But generally the malicious vaccine of the work of Shi Yonging will be residual, and during this made that the import and export of bird product are quarantined, the recall rate of newcastle disease live virus was up to 10%-20%.For the Avian pneumo-encephalitis virus that is separated to, can not distinguish malicious vaccine of the residual work of immunization or the wild poison that infects fully owing to there is method at present, and the higher wild poison of toxicity may cause the propagation and the outburst of newcastle disease, so OIE (Anon, 2000) regulation must be carried out loaded down with trivial details to the Avian pneumo-encephalitis virus that is separated in importing and exporting, (10-40 days) consuming time, the toxicity test of expensive routine (comprising ICPI, MDT or IVPI).The high recall rate of Avian pneumo-encephalitis virus and very long sense cycle have influenced the foreign exchange earning of poultry product greatly.
For solving this technical barrier, developed some at present and distinguished RT-PCR method (He Dongsheng etc., 2000 of strong poison of newcastle disease and weak poison fast; Shan SH et al., 2003).But its theoretical basis is based upon strong poison of minority and the difference of weak malicious nucleotide sequence at guiding region minority Nucleotide, substantially do not relate to the morbific molecular basis of Avian pneumo-encephalitis virus, theoretical basis is not very abundant, and the sequence quantity of design of primers reference, the quantity of checking sample is all on the low side, and actual to apply difficulty bigger.
Along with development of molecular biology, the particularly automatization of gene sequencing technology, commercialization and cost degradation (being no more than 60 yuan/reaction) in export quarantine, relatively come identifying virus to become possibility by gene sequencing.The NDV fingerprint sequence of the one section about 400bp that finds among the present invention can not only be as the molecule marker of distinguishing newcastle disease virus and vaccine virus, and this sequence also can be used for gene type, and comprises the cracking site of F gene, can infer the genotype and the virulence of virus.Information biology and development of computer make loaded down with trivial details sequential analysis work of later stage to finish automatically by writing relevant program.
Summary of the invention
The objective of the invention is to go up the difference diagnosis difficult problem that newcastle disease virus infects and attenuated live vaccines is residual in order to solve to produce, by the RT-PCR-sequencing technologies, with the multifunction automatic analysis software of exploitation, distinguish newcastle disease virus and vaccine virus, and finish wild virulence and genotypic mensuration synchronously.
RT-PCR-sequence measurement of the present invention and automated analysis software reach by following measure:
1.F gene fragment 22-420 sequence is the most frequently used malicious vaccine virus of work as the discovery La Sota that distinguishes newcastle disease virus and vaccine virus molecule marker, so we get La Sota (AF077761) sequence as standard, use Vector NTI 8.0 to analyze other NDV sequence (from GenBank) and its homology (table 1), and carry out ASSOCIATE STATISTICS analysis (table 2) with SPSS (10.0).The result shows, F gene fragment (22-420) and F gene (ORF), and the NDV whole genome sequence has high correlation, and relation conefficient reaches 0.969 and 0.966.Therefore can be used as the molecule marker of distinguishing newcastle disease virus and vaccine virus.
Table each strain of 1:NDV and La Sota (AF077761) homology are relatively
Numbering The gene sequence number NDV sheet segment limit Strain isolated
F gene 22-420 fragment F gene ORF (1662nt) Full-length gene group (about 15186nt)
Homology (%) Homology (%) Homology (%)
A
1 Y18898 100 99.9 99.8 Clone 30 (the cDNA sequencing result of La Sota)
2 AY225110 100 99.8 94.4 HB92 isolate V4(La Sota)
3 AF375823 99.2 99.2 99.0 B1(La Sota)
4 AF309418 99.0 98.9 98.9 B1(La Sota)
5 NC_002617 99.0 98.9 98.9 B1(La Sota)
6 AF431744 81.7 84.5 83.2 ZJ1
7 NC_005036 81.0 84.4 83.1 SF02(Goose)
B
8 AF534997 100 99.9 ZJ/2000
9 AY359876 100 99.9 NDVCUL97
10 AF079323 100 99.4 DB5
11 AF079324 99.7 99.8 PNDV1
12 AF099661 99.7 99.6
13 AF400614 99.0 98.9 NDV-JL-1/97
14 M24696 98.7 98.8 La Sota/46
15 M24695 98.2 98.9 BI/47(La Sota)
16 M24698 96.2 97.4 TEX/48
17 M24697 96.0 97.4 BEA/45
18 M24703 96.0 97.4 ITA/45
19 M24694 88.5 90.6 ULS/67
20 M24692 87.0 89.7 D26/76
21 AY427817 87.0 89.1 Heb02
22 AF217084 86.5 89.9 Strain:Queensland, isolate:V4
23 M24693 86.2 89.5 Que/66
24 M21881 85.2 90.1 Australia-Victoria
25 M24700 85.0 90.0 AUS/32
26 AY341061 84.5 89.2 LuoY
27 AF163440 84.5 89.0 F48E9
28 M17710 84.5 89.0
29 AF048763 84.5 87.8 AF2240
30 M24702 84.2 89.2 HER/33
31 M18456 84.2 88.9 Miyadera
32 M24701 84.2 88.9 MIY/51
33 M33855 84.0 88.7
34 AF079172 84.0 88.9 F48E9
35 AY508514 84.0 89.0 F48E9
36 AF079322 83.7 93.1 DB3
37 AF109885 82.5 85.2 GB 1168/84
38 AY253912 81.7 84.7 YN-PA01
39 AF358787 81.7 84.6 Ch/99
40 AF456438 81.7 84.5 ZJ/1/00/Go
41 AY325909 81.7 83.2 YN-C2
42 AF456442 81.5 84.9 JS/5/01/Go
43 AF358788 81.5 84.7 Ch/2000
44 AY337464 81.5 84.7 From goose
45 AF400615 81.2 91.7 NDV-JL-2/97
46 AY325799 81.2 84.5 YN-C1
47 AF364835 81.0 84.7 Ch/98-3
48 AF358785 80.5 84.4 Ch/98-1
49 AF358786 80.2 84.4 TW/2000
50 AY338284 79.4 84.1 Y98
51 AY325798 79.4 83.2 Pigeon paramyxovirus-1,YN-P1
Table 2:F gene fragment (22-420), the dependency statistical study of F gene (ORF) and NDV genome sequence homology
F gene (ORF) Genome
T gene fragment (22-420) The two tails of the correlation coefficient r probability sample number that accompanies 0.969 ** 0.000 51 0.966 ** 0.000 7
F gene (0RF) The two tails of the correlation coefficient r probability sample number that accompanies / 0.966 ** 0.000
Dependency is remarkable on the * .0.01 level
2. the design of amplification newcastle disease F gene fragment 22-420 degenerated primer:
P+:5’ATG GGC ICC AIA ICT TCT ACC 3’
P-:5’CAT TGG TTG CIG CAA TGC TCT C 3’
The primer explanation:
(1) P+The corresponding NDV-F gene of primer 1-21 fragment sequence; P-The corresponding NDV-F gene of primer 466-487 fragment sequence;
(2) P+Primer design is with reference to 194 NDV F gene sequences (AF309418, AF077761, AY225110 including among the GenBank, NC_002617, Y18898, AF431744, AF375823, NC_005036, M24693, M24692, M21881, M18456, M17710, AY508514, AY427817, AY359876, AY341061, AY338284, AY337464, AY325909, AY325799, AY253912, AF1634400, AF534997, AF456442, AF456438, AF400615, AF400614, AF364835, AF358788, AF358787, AF358786, AF217084, AF109885, AF099661, AF079324, AF079323, AF079322, AF079172, AF048763, AF358785, AF325798. AF001105, AF001106, AF001107, AF001108, AF001109, AF001110, AF001111, AF001112, AF001113, AF001114, AF001115, AF001116, AF001117, AF001118, AF001119, AF001120, AF001121, AF001122, AF001123, AF001124, AF001125, AF001126, AF001127, AF001128, AF001129, AF001130, AF001131, AF001132, AF001133, AF0011314, AF001135, AF091623, AF109876, AF109877, AF109878, AF109879, AF109880, AF109881, AF109882, AF109883, AF109884, AF109886, AF109887, AF263615, AF378245, AF378246, AF378247, AF378248, AF378249, AF378250, AF378251, AF378252, AF378253, AF378254, AF378255, AF378256, AF378257, AF378258, AF378259, AF378260, AF400616, AF401999, AF456435, AF456436, AF456437, AF456438, AF456439, AF456440, AF456441, AF456442, AF456443, AF456444, AF520592, AY135740, AY135741, AY135742, AY135743, AY135744, AY135745, AY135746, AY135747, AY135748, AY135749, AY135750, AY135751, AY135752, AY135753, AY135754, AY135755, AY135756, AY135757, AY135758, AY135759, AY289194, AJ306304, AJ306305, Y19012, Y19015, Y19017, AY117021, AY117022, AY117023, AY117024, AY117025, AY150125, AY150126, AY150127, AY150128, AY150129, AY150130, AY150131, AY150132, AY150133, AY150134, AY150135, AY150136, AY150137, AY150138, AY150139, AY150140, AY150141, AY150142, AY150143, AY150144, AY150145, AY150146, AY150147, AY150148, AY150149, AY150150, AY150151, AY150152, AY150154, AY150155, AY150156, AY150157, AY150158, AY150159, AY150160, AY150161, AY150162, AY150163, AY150164, AY150165, AY151383, AY151384, AY151385, AY170136, AY170137, AY170138, AY170139, AY170140, AY190518, AY252120.), the homology comparison result is referring to Fig. 1.
(3) P-Design reference 75 NDV F gene sequences (AF309418, AF077761, AY225110, NC_002617 that include among the GenBank, Y18898, AF431744, AF375823, NC_005036.M24693, M24692, M21881, M18456, M17710, AY508514, AY427817, AY359876, AY341061, AY338284, AY337464, AY325909, AY325799, AY253912, AF1634400, AF534997, AF456442, AF456438, AF400615, AF400614, AF364835, AF358788, AF358787, AF358786, AF217084, AF109885, AF099661, AF079324, AF079323, AF079322, AF079172, AF048763, AF358785, AF325798, AF378245, AF378246, AF378247, AF378248, AF378249, AF378250, AF378251, AF378252, AF378253, AF378254, AF378255, AF378256, AF378257, AF378258, AF378259, AF378260, AF400616, AF401999, AF456435, AF456436, AF456437, AF456438, AF456439, AF456440, AF456441, AF456442, AF456443, AF456444, AJ306304, AJ306305, Y19012, Y19015, Y19017), the homology comparison result is referring to Fig. 2.
(4) I represents inosine, can with A, T, G, C complementary (molecular cloning second edition p543) increase the degeneracy of primer, P+In introduced 3 I, P-In introduced 1 I.
(5) because of NDV is a minus-stranded rna virus, select for use P+Do RT reaction primer;
(6) unreliable because of sequencing near primer 2 0-30nt, select for use P-Do sequencing primer.
3. the extracting of viral nucleic acid RNA
(1) getting vaccine virus dry powder (8mg) dissolves with 100 μ l PBS; Or get allantoic fluid 100 μ l. to be detected
(2) add 900 μ l TRIzol reagent (Gibco-BRL company), mixing, room temperature 5min;
(3) add 0.2ml or an amount of chloroform, room temperature left standstill 3 minutes behind the vibration mixing;
(4) 12000g, 4 ℃, centrifugal 15 minutes;
(5) carefully draw supernatant to new 1.5ml centrifuge tube;
(6) add 0.5ml or an amount of Virahol, room temperature was placed 10 minutes behind the concussion mixing;
(7) 12000g, 4 ℃, centrifugal 10 minutes;
(8) 75% washing with alcohol of abandoning supernatant adding 0.5ml once;
(9) 12000g, 4 ℃, centrifugal 5min;
(10) abandoning supernatant, precipitation are put 37 ℃ of oven dry 10min;
(11) add 20 μ l RNase free ddH 2The O dissolving.
4.RT-PCR amplification
The A.RT reaction:
(1) adds 2 μ l P+(10pmol/ μ l) is in the nucleic acid of 10 μ l;
(2) 100 ℃ of insulation 3min;
(3) insert 5min in the ice fast;
(4) add 5X AMV RTase buffer 4 μ l, dNTP mixture (10mM) 2 μ l, Ribonuclease inhibitor1 μ l (TaKaRa company), AMV RTase (5U/ μ l) 1 μ l (TaKaRa company).Stir gently;
(5) room temperature 10min;
(6) move into 42 ℃ of water bath with thermostatic control insulations 1 hour;
(7) reaction solution all is used for the PCR reaction.
The B.PCR reaction:
(8) add
10X PCR Buffer(Mg 2+free) 20μl;
MgCl 2(25mM) 12μl;
dNTP(2.5mM) 16μl;
P+(10pmol/μl) 8μl;
P-(10pmol/μl) 8μl;
RTaq (5U/ μ l) 1 μ l; (TaKaRa company)
RT product 20 μ l;
ddH 2O 115μl
Total 200μl
(9) 100 μ l are sub-packed in 2 thin-walled tubes behind the mixing; The PCR reaction.
(10) PCR reaction conditions:
94℃ 4mins
72℃ 10mins
(11) get 15 μ l detected through gel electrophoresis (product is 480bp greatly down).
5.PCR product directly checks order
After getting 170 μ l PCR products (remaining 15 μ l-20 ℃ deposits) and sending biotech company rubber tapping to reclaim, carry out the PCR product and check order directly that (the purpose band is positioned at 480bp, uses P-As sequencing primer).
6.F the mensuration of gene fragment 22-420 sequence variations parameter
Choose the same lot number of same producer, different lot numbers, La Sota vaccine and variant and mixed vaccine totally 22 strains that different manufacturers is produced, carry out the nucleic acid extracting with aforesaid method, RT-PCR amplification and order-checking, and analyze itself and the nucleotide difference of standard La Sota (AF077761), acquisition F gene of NDV strain fragment 22-420 sequence variations parameter, result such as table 3 with biosoftware Vector NTI 8.0.Also chosen the same lot number of same producer simultaneously, the mesogenic living vaccine (I system) that different lot numbers, different manufacturers are produced totally 5 strain amplifications and order-checking verifies that discovery has only the variation of 1 Nucleotide, and the result who obtains with La Sota is consistent.
The mensuration of table 3. various La Sota vaccine strain and standard La Sota (AF077761) F gene fragment 22-420 sequence variations number:
Nucleotide diversity is counted the hundreds of proportions by subtraction of vaccine strain 0 19 86.4% 1 2 9.1% 4 1 4.5%
As shown in Table 3, the sequence major part (86.4%) of F gene fragment 22-420 is variation not, has only minority (4.5%) that the variation of 4 Nucleotide is arranged.This variation is from the error of the sudden change and the operation of gene, and the variation parameter of mensuration is used to set the threshold value of newcastle disease virus and vaccine virus differentiation.
7.NDV the mensuration of standard living vaccine F gene fragment 22-420 sequence library
Collect various newcastle diseases commonly used malicious vaccine alive both at home and abroad, analyze, be classified as 4 classes according to homology with aforesaid method mensuration sequence and with biosoftware Vector NTI 8.0.Its standard sequence is referring to table 4.The further feature of four class standard newcastle diseases malicious vaccine alive is referring to table 5 and table 6.
Table 4. is NDV standard living vaccine F gene fragment 22-420 sequence library both at home and abroad:
The vaccine title Sequence (F gene fragment 22-420)
La Sota AAGAACCCAGCACCTATGATGCTGACTATCCGGGTTGCGCTGGTACTGAGTTGCATCTGTCCGGCAAACTCCATTGATGGC AGGCCTCTTGCAGCTGCAGGAATTGTGGTTACAGGAGACAAAGCCGTCAACATATACACCTCATCCCAGACAGGATCAATC ATAGTTAAGCTCCTCCCGAATCTGCCCAAGGATAAGGAGGCATGTGCGAAAGCCCCCTTGGATGCATACAACAGGACATTG ACCACTTTGCTCACCCCCCTTGGTGACTCTATCCGTAGGATACAAGAGTCTGTGACTACATCTGGAGGGGGGAGACAGGGG CGCCTTATAGGCGCCATTATTGGCGGTGTGGCTCTTGGGGTTGCAACTGCCGCACAAATAACAGCGGCCGCAGCT
Avinew AGGATCCCAGTACCTCTTATGCTGACCGTCCGAGTCATGTTGGCACTGAGTTGCGTCTGTCCGACCAGCGCCCTTGATGGC AGGCCTCTTGCAGCTGCAGGGATTGTGGTAACAGGAGACAAAGCAGTCAACATATACACCTCATCTCAGACAGGGTCAATC ATAATCAAGTTACTCCCAAATATGCCCAAGGATAAAGAGGCGTGTGCAAAAGCCCCGTTGGAGGCATACAACAGGACATTG ACTACTTTGCTCACCCCCCTTGGTGATTCTATCCGTAGGATACAAGAGTCTGTGACCACGTCCGGAGGAGGGAAACAGGGA CGTCTTATAGGCGCCATTATCGGTGGTGTAGCTCTCGGGGTTGCAACCGCTGCACAGATAACAGCAGCCTCGGCT
V.H. AGGATCCCAGTACCTCTGATGCTGACCGTCCGATTTGTGCTGGCACTGAGTTGCATCTGTCCGACTAGCTCCCTTGATGGC AGGCCTCTTGCAGCTGCAGGGATTGTGGTAACAGGAGACAAAGCAGTCAACATATACACCTCATCTCAGACAGGGTCAATC ATAGTCAAGTTACTCCCAAATATGCCCAAAGATAAAGAGGCGTGTGCAAAAGCCCCGTTGGAGGCGTACAACAGGACATTG ACCACTTTGCTCACCCCCCTTGGTGATTCTATCCGTAGGATACAAGAGTCCGTGACCACATCTGGAGGAGGGAAACAAGGA CGCCTTATAGGCGCCATTATCGGTGGTGCAGCTCTCGGGGTTGCAACCGCTGCACAGATAACAGCAGCCTCGGCT
Newcastle disease I system AGGATCCCAGTACCTCTAATGCTGACCATACGGATCACGCTGGCACTGAGTTATGTCCGTCTGACAAGTTCTCTTGATGGC AGGCCTCTTGCAGCCGCAGGGATCGTGGTAACAGGGGATAAAGCAGTTAACATATACACCTCATCCCAGACAGGGTCAATC ATAGTCAAGTTACTCCCAAATATGCCCAAGGACAAAGAGGCATGTGCAAAAGCCCCATTGGAGGCTTACAACAGGACACTG ACTACTTTGCTTACCCCCCTTGGTGATTCTATCCGCAGGATACAAGAGTCTGTGACTACATCCGGAGGAAGGAGACAGAGA CGCTTTATAGGTGCCATTATTGGCAGTGTAGCTCTAGGGGTTGCAACAGCTGCACAGATAACGGCAGCCTCGGCT
Table 5.The feature of domestic and international NDV standard malicious vaccine alive
The vaccine title Virulence F gene cracking site aminoacid sequence Genotype Out of Memory
La Sota Weak poison 112GRQGRL II Comprise La Sota and variant thereof the system (B59, N79, B1)
Avinew Weak poison 112GRQGRL I With newcastle disease V4-Queensland (AF217084) strain is that sequence is consistent
V.H. Weak poison 112GRQGRL I With newcastle disease Tol (AY39035) strain be that sequence differs a base
Newcastle disease I system Poison 112RRQRRF III It is newcastle disease Mukteswar strain system
The homology of table 6. four class standard vaccine sequences and the difference number of Nucleotide.
Figure A20051006064600121
8. the exploitation of multifunction automatic analysis software
(1) foundation of 3 databases of software analysis use
In order to distinguish newcastle disease virus and vaccine virus, measure and set up the standard vaccine sequence library, referring to table 4; In order to measure the virulence of Avian pneumo-encephalitis virus, reference (Collins MS et al., 1993; Luo Jun etc., 2002) set up in, strong malicious cracking site sequence library (table 7); In order to measure the genotype of Avian pneumo-encephalitis virus, reference (Lomniczi B, 1998; Shan SH et al., 2003) set up 7 kinds of genotype standard strain sequence libraries (table 8).
In the table 7., strong malicious cracking site aminoacid sequence storehouse
F gene cracking site sequence Virulence is inferred Out of Memory
112R/K-R/K-X-K/R-K/R-F 117 Strong poison or poisoning X represents arbitrary amino acid, strong malicious Avian pneumo-encephalitis virus in the major part,
112G-K/R-X-K/R-R/K-F 117 Strong poison or poisoning X represents arbitrary amino acid, some dove Avian pneumo-encephalitis virus
Other sequence Poison or weak poison Weak malicious Avian pneumo-encephalitis virus, and mutating experiment evidence
Seven kinds of genotype standard strains of table 8. sequence library (F gene fragment 22-389)
Strain name Accession numbe Genotype
Ulster D00243 I
V4/66 AF217084 I
Beaudette/C45 X04719 II
La Sota/46 M24696 II
Miyadera/51 M18456 III
Aus Victoria/32 M21881 III
F48E9 AY508514 III
Herts/33 M24702 IV
Italien M17710 IV
CA1085/71 AF001106 V
NY70181 AF001105 V
Warwick/66 Z12111 VI
GB1168 AF109885 VI
Taiwan95 U62620 VII
QY97 AF162714 VII
Table 9: wild poison is distinguished the combination criterion of wild virulence (X represents the vaccine title that homology is the highest) with vaccine virus
(2) setting of the schema of software analysis and combination criterion
The software analysis schema is referring to Fig. 3.Because of P-is a sequencing primer, acquisition be complementary sequence, need to analyze after the counter-rotating.The purpose of joining with standard sequence La Sota homology connection is to treat order-checking row location, accurately cuts out target sequence.The fragment 22-420 that obtains is used for the differentiation of newcastle disease virus and vaccine virus; The fragment 334-351 F gene cracking site aminoacid sequence (112-117) of encoding is used to infer virus virulence; Fragment 22-389 is used for the gene type analysis, infers the genotype of virus.Discover that the sudden change on the virolysis site may produce bigger influence (Li Z et al., 1998 to virus virulence; Peeters BPHet al., 1999; Yu SQ, 2002), thus software must distinguish virulence may enhanced vaccine variant, this just need take all factors into consideration viral nucleic acid variation parameter to be checked and virulence is inferred parameter, sets up and makes up decision condition.Simultaneously, the judgement that is in threshold boundaries is judged by accident easily, sets up doubtful vaccine virus can reduce the probability of probability of miscarriage of justice.Combination criterion is referring to table 9.
(3) writing of software:
Software adopts C++builder 6.0 to write, and the auxiliary tone of homology connection is grown tree analysis (gene type) and called free shareware phylip software package with free shareware Clustal W (1.83) multiple sequence alignment software package in the program.
(4) software uses the step brief introduction:
Software master interface is referring to Fig. 4.Click " load sequence " button, list entries (Fig. 5); Click " Detect " button, after selection result was preserved the position, software was analyzed automatically, and exported result (Fig. 6) with the form of form.Click " Vaccine manager " button, enter " Vaccine setup " dialog box, under the situation of not revising source routine, can make amendment to the standard vaccine storehouse easily, add and deletion (Fig. 7)." Options " button can be revised the threshold value (Fig. 8) of wild poison and vaccine virus differentiation.
9. method specificity, the detection of susceptibility and reliability:
(1) method specific detection.Choose clinical symptom and the closely similar bird flu of newcastle disease disease, duck hepatitis virus, avian infectious bronchitis virus, coccidia virus, Marek ' s virus, infections chicken cloacal bursa virus, the negative control that virus-free allantoic fluid detects as RT-PCR, the positive detection sample has then been chosen some type strain F48E9 (strong poison) of NDV, La Sota (weak poison), N79 (weak poison), Muktastwar (poisoning), B59 (weak poison), Clone 30 (weak poison) etc.Result such as Fig. 9.
All negative controls all do not amplify band at the 480bp place, and all positive detection samples all amplify the purpose fragment at the 480bp place, prove that present method has higher specificity.The minority positive also amplifies an assorted band at the 300bp place, consider it is the rubber tapping order-checking, and the existence of assorted band can not produce any influence to the result.
(2) the present invention has only detected the sensitivity of RT-PCR.Consider as long as RT-PCR can amplify the purpose fragment, just can obtain enough products for further order-checking, so the key of the inventive method is the sensitivity of RT-PCR by constantly increasing.Collection standard Avian pneumo-encephalitis virus F48E9 and La Sota allantoic fluid are measured its virus titer ELD with the Reed-Muench method respectively 50, and carry out 10 times of gradient dilutions, carry out RT-PCR amplification, result such as Figure 10 behind the extraction nucleic acid.It is 10 that RT-PCR detects F48E9 sensitivity 1.5ELD 50/ ml, detecting La Sota is 10 1.7ELD 50/ ml.
(3) detection of method reliability.Choose F48E9, Komorov, La Sota, Mukteswar, N79, Roakin, V.H, newcastle disease I system, Avinew, B1, B59, standard newcastle disease strains such as Clone 30 detect result such as Figure 11 with method of the present invention.Because N79, B1, B59, Clone 30 are variant systems of La Sota, so detected result shows that it is a La Sota vaccine, coincide with the fact; Newcastle disease I system is a Mukteswar strain system, so the Mukteswar detected result is a living vaccine for mesogenic I, coincide with the fact.12 strain standard newcastle disease strain detected results and Given information are in full accord, show that method of the present invention has high reliability.
The invention has the beneficial effects as follows: can be accurate, (3 days) are special fast, distinguish newcastle disease virus and vaccine virus easily, and can measure its virulence and genotype synchronously.The multifunctional analysis software operation of exploitation is easy, and parameter (standard vaccine sequence library and differentiation threshold value) can conveniently be revised, and upgrading has very big handiness.The present invention is suitable for the bird inspection and quarantine department and bird breed factory promotes the use of.To the foreign exchange earning of bird product, the monitoring and warning of newcastle disease has very high using value.
Description of drawings
Different N DV strain was the result (Vector NTI8.0) that the sequence homology connection is joined when Fig. 1 was the P+ design.Consensus represents conserved sequence.
Different N DV strain was the result (Vector NTI8.0) that the sequence homology connection is joined when Fig. 2 was the P-design.Consensus represents conserved sequence.
Fig. 3 is the software design schema.
Because of P-is a sequencing primer, acquisition be complementary sequence, need to analyze after the counter-rotating.The purpose of joining with standard sequence La Sota homology connection is to treat order-checking row location, accurately cuts out target sequence.The fragment 22-420 that obtains is used for the differentiation of newcastle disease virus and vaccine virus; The fragment 334-351 F gene cracking site aminoacid sequence (112-117) of encoding is used to infer virus virulence; Fragment 22-389 is used for the gene type analysis, infers the genotype of virus.
Fig. 4 is automated analysis software-new city vaccine virus despot's 2004 the main interface of analysis.
" Load sequence " button is imported sequence to be measured, and the result is analyzed and exported to " Detect " button software automatically." Vaccine Manager " button is made amendment to the standard vaccine sequence library that software includes, and adds deletion." Options " button is made amendment to vaccine and wild contaminated area branch threshold value." Close " close software." candidate Sequences " shows sequence title to be analyzed." Origin Sequence " original series of display analysis." detect result " display analysis result.
Fig. 5 is the software interface after the sequence input,
Fig. 6 is software detection interface as a result.
The hyperlink of click details can show the detailed content in the testing process.
Fig. 7 is the window that the standard vaccine sequence library is revised.
" Add " adds new vaccine, and " Edit " makes amendment to existing vaccine information, and the existing vaccine of " Delete " deletion, " OK " are preserved and revised the result, and the result is revised in " Cancel " cancellation.
Fig. 8 is the modification window that newcastle disease virus and vaccine virus are distinguished threshold value.
" Max Vaccine mutation count " is the maximum variance of vaccine, and " Max Doubt Vaccine MutationCount " is the maximum variance of doubtful vaccine.
Fig. 9 is a RT-PCR specificity experimental result.
1.100bp DNA Ladder Marker (TaKaRa); 2. allantoic fluid; 3. bird flu H5; 4. bird flu H9; 5. duck hepatitis virus (DHV); 6. chicken infectious bronchitis living vaccine (H120) (Shanghai Songjiang biologics factory); 7. fryer coccidiosis living vaccine (Shandong animal health product factory); 8.Marek ' s Disease Vaccine Serotype 3, Live Virus (Merial SELECT INC); 9. infectious bursal disease bivalent live vaccine (Yi Kang of Liaoning Province biological factory); 10.F48E9; 11.La Sota; 12.Muktaswar; 13.B59; 14.N79; 15.Clone 30; 16.100bp DNA LadderMarker (TaKaRa). all positive sample amplified band all occurs at the 480bp place.Negative control does not have amplified band.The part positive sample impurity removal band that also increases at the 300bp place because of the present invention adopts the rubber tapping order-checking, can not produce any influence to the result.
Figure 10 is RT-PCR sensitivity experiment result.
1.100bp DNA Ladder Marker (TaKaRa); 2.10 3.5ELD 50/ ml F48E9 allantoic fluid; 3.10 2.5ELD 50/ ml F48E9 allantoic fluid; 4.10 1.5ELD 50/ ml F48E9 allantoic fluid; 5.10 0.5ELD 50/ ml F48E9 allantoic fluid; 6.10 3.7ELD 50/ ml LaSota allantoic fluid; 7.10 2.7ELD 50/ ml La Sota allantoic fluid; 8.10 1.7ELD 50/ ml La Sota allantoic fluid; 9.10 0.7ELD 50/ ml La Sota allantoic fluid; 10.10 -0.3ELD 50/ ml La Sota allantoic fluid.
Figure 11. be the reliability demonstration result of novel method bioassay standard newcastle disease strain.
Because N79, B1, B59, Clone 30 are variant systems of La Sota, so detected result shows that it is a La Sota vaccine, coincide with the fact; Newcastle disease I system is a Mukteswar strain system, so the Mukteswar detected result is a living vaccine for mesogenic I, coincide with the fact.12 strain standard newcastle disease strain detected results and Given information are in full accord.
Figure 12. part is separated the electrophorogram of newcastle disease strain RT-PCR product among the embodiment 1.
1.100bp DNA Ladder Marker (TaKaRa); 2. allantoic fluid; 3. isolating newcastle disease virus in the goose; 4. isolating newcastle disease virus in the pigeon; 5. isolating newcastle disease virus in the chicken; 6. isolating newcastle disease virus in the ostrich.
Embodiment 1-separates the detection of newcastle disease strain
1. Bing Du separation and evaluation.
According to the method for " diagnostic test and vaccine manual of standards " (International Office of Epizootics writes, 1996), from goose, pigeon, chicken is isolated 51 strain Avian pneumo-encephalitis virus in the ostrich.
2. the extracting of viral nucleic acid RNA
(1) gets allantoic fluid 100 μ l. to be detected
(2) add 900 μ l TRIzol reagent (Gibco-BRL company), mixing, room temperature 5min;
(3) add 0.2ml or an amount of chloroform, room temperature left standstill 3 minutes behind the vibration mixing;
(4) 12000g, 4 ℃, centrifugal 15 minutes;
(5) carefully draw supernatant to new 1.5ml centrifuge tube;
(6) add 0.5ml or an amount of Virahol, room temperature was placed 10 minutes behind the concussion mixing;
(7) 12000g, 4 ℃, centrifugal 10 minutes;
(8) 75% washing with alcohol of abandoning supernatant adding 0.5ml once;
(9) 12000g, 4 ℃, centrifugal 5min;
(10) abandoning supernatant, precipitation are put 37 ℃ of oven dry 10min;
(11) add 20 μ l RNase free ddH 2The O dissolving.
2.RT-PCR amplification and PCR product directly check order:
Wherein: P+: 5 ' ATG GGC ICC AIA ICT TCT ACC 3 '
P-:5’CAT TGG TTG CIG CAA TGC TCT C3’
The A.RT reaction:
(1) adds 2 μ l P+(10pmol/ μ l) is in the nucleic acid of 10 μ l;
(2) 100 ℃ of insulation 3min;
(3) insert 5min in the ice fast;
(4) add 5X AMV RTase buffer 4 μ l, dNTP mixture (10mM) 2 μ l, Ribonuclease inhibitor1 μ l (TaKaRa company), AMV RTase (5U/ μ l) 1 μ l (TaKaRa company).Stir gently;
(5) room temperature 10min;
(6) move into 42 ℃ of water bath with thermostatic control insulations 1 hour;
(7) reaction solution all is used for the PCR reaction.
The B.PCR reaction:
(8) add
10X PCR Buffer(Mg 2+free) 20μl;
MgCl 2(25mM) 12μl;
dNTP(2.5mM) 16μl;
P+(10pmol/μl) 8μl;
P-(10pmol/μl) 8μl;
RTaq (5U/ μ l) 1 μ l; (TaKaRa company)
RT product 20 μ l;
ddH 2O 115μl
Total 200μl
(9) 100 μ l are sub-packed in 2 thin-walled tubes behind the mixing; The PCR reaction.
(10) PCR reaction conditions:
94℃ 4mins
72℃ 10mins
(11) (product is 480bp greatly down, Figure 12) to get 15 μ l detected through gel electrophoresis
The C.PCR product directly checks order
(12) get 170 μ l PCR products (remaining 15 μ l-20 ℃ deposits) and send biotech company rubber tapping to reclaim after, carry out the PCR product and check order directly that (the purpose band is positioned at 480bp, uses P-As sequencing primer).
3. with newcastle disease poison despot sequence is analyzed:
(1) E-mail collects the sequencing result of company;
(2) start newcastle disease poison despot software, enter and analyze main interface.
(3) click " load sequence " button, list entries;
(4) click " Detect " button, software requires selection result to preserve the position earlier, and after determining, the result is promptly analyzed and export to software automatically.
4. result's statistics is as table 10.In the 51 strain isolated strains, vaccine accounts for 58.8%; Doubtful vaccine is 3.9%; Wild poison does not detect V.H and newcastle disease I system for mainly being La Sota in the 37.3%. vaccine; In the wild poison mainly is gene VII type, gene VI type and gene II type.
Table 10.51 strain isolated strain RT-PCR-order-checking and software analysis result
Vaccine Doubtful vaccine Wild poison
LaSota Avinew La Sota Avinew Gene II type Gene VI type Gene VII type
The hundreds of proportions by subtraction of strain 28 54.9% 2 3.9% 1 2.0% 1 2.0% 2 3.9% 5 9.8% 12 23.5%
Total per-cent 58.8% 3.9% 37.3%
The main reference document
He Dongsheng, Qin Zhifeng, Liu Fuan. the differential diagnosis of Avian pneumo-encephalitis virus Phylogenetic Analysis and strong and weak strain. animal medicine progress .2000.21 (2): 27-31.
Luo Jun, Gong Xia etc. the detection and the discriminating of Avian pneumo-encephalitis virus (fowl I type paramyxovirus). animal and veterinary logical flood 2002.3:10-13. International Office of Epizootics in Shanghai writes. diagnostic test and vaccine manual of standards [M] .1996,140-146.
Alexander DJ.(1982)Avian paramyxoviruses-other than Newcastle disease virus.World Poultry Sciences.38:97-104.
Alexander,D.J.(1997)Newcastle disease and other avian Paramyxoviridae infections.In Diseases of poultry,10th edn,pp.541-569.Edited by B.W.Calnek.Ames:Iowa State University Press.Anon.(2000)Newcastle disease.International Health Code,9 th Edn.Office International des Epizootes.
http://www.oie.int/eng/en index.htm.
Chen L.,Gorman JJ.,McKimm-Breschkin J.,et al.(2001)The structure of the fusion glycoprotein of Newcastledisease virus suggests a novel paradigm for the molecular mechanism of menbrane fusion.Structure..9:255-266.
Collins MS,Bashiruddin JB,Alexander DJ.1993.Deduced amino acid sequences at the fusion protein cleavagesite of Newcastle disease viruses showing variation in antigenicity and pathogenicity.Arch Virol.128(3-4),363-70.
Glickman R L,Syddal R J,lorio R M,Sheehan J P,Bratt M A.(1988)Quantitative basic residue requirements inthe cleavage activation site of the fusion glycoprotein as a determinant of virulence for Newcastle diseasevirus.Journal of Virology.62:354-356.
Li Z.,Sergel T.,Razvi E.,et al.(1998)Effect of cleavage mutants on syncytium formation directed by thewild-type fusion protein of Newcastle disease virus.Journal of Virology,72:3789-3795.
Liu XFWan HQNi XXWu YTLiu WB.(2003).Pathotypical and genotypical characterization of strains ofNewcastle disease virus isolated from outbreaks in chicken and goose flocks in some regions of Chinaduring 1985-2001.Arch Virol.148(7),1387-403.
Lomniczi,B.,Wehmann,E.,Herczeg,J.,Ballagi-Pordany,A.,kaleta,E.F.,Werner,O.,Meulemans,G.,Jorgensen,P.H.,Manté,A.P.,Gielkens,A.L.J.,Capua,I.&Damoser,J.(1998)Newcastle disease outbreaks inrecent years in Western Europe were caused by old(VI)and a novel genotype(VII).Archives of Virology.143:49-64.
Peeters BPH.,de Leeuw OS.,Koch G.,et al.(1999)Rescue of Newcastle disease virus from cloned cDNA:evidence that cleavability of the fusion protein is a major determinant for virulence.Journal of Virology,73:5001-5009.
Rima,BK.,Alexander,DJ.,Billeter,MA.,Collins,PL.,Kingsbury,DW.,Lipkind,MA.,Nagai,Y.,Orvell C.,Pringle,CR.&ter Meulen,V.(1995)The Paramyxoviridae.In Virus Taxonomy.Sixth Report of theInternational Committee on Taxonomy of Viruses,pp.268-274.Edited by F.A.Murphy,C.M.Fauquet,&D.H.Summers.Vienna & New York:Springer-Verlag.
Shan SH,Shao CG,Zou J et al.(2003)lsolation and identification of genotype VII Newcastle disease virus(NDV)from an import pigeon.Chinese Journal of Virology.19(4),360-364.
Toyoda T.,Sakaguchi T.,Hirota H.,et al.(1989)Newcastle Disease Virus Evolution.II.Lack of GeneRecombination in Generating Virulent and Avirulent Strains.Virology.169,273-282.
Yu,S.Q.,Kishida,N.,Ito,H.,Kida,H.,Otsuki,K.,Kawaoka,Y.&Ito,T.(2002)Generation of VelogenicNewcastle Disease Viruses from a Nonpathogenic Wateffowl lsolate by Passaging in Chickens.Virology.301:206-211

Claims (10)

1. one kind is used for newcastle disease virus and vaccine virus difference diagnosis, the detection method that virulence and genotype are measured synchronously, comprise the extracting of viral nucleic acid, the RT-PCR amplification, the PCR product send biotech firm's rubber tapping order-checking, the information biology software analysis of sequence, in it is characterized in that detecting, adopted one section to can be used as molecule marker, and contain F gene cracking site and the segmental multi-usage newcastle disease virus gene of gene type sequence, amplify the purpose fragment by a pair of special degenerated primer, write specific information biology software sequencing result is analyzed.
2. newcastle disease virus according to claim 1 and vaccine virus difference diagnosis, the detection method that virulence and genotype are measured synchronously is characterized in that this multi-usage newcastle disease virus gene sequence is F gene of NDV strain fragment 22-420.
3. newcastle disease virus according to claim 1 and vaccine virus difference diagnosis, the detection method that virulence and genotype are measured synchronously is characterized in that two special degeneracy amplimer sequences are:
P+:5’ATG GGC ICC AIA ICT TCT ACC 3’
P-:5’CAT TGG TTG CIG CAA TGC TCT C 3’
4. newcastle disease virus according to claim 1 and vaccine virus difference diagnosis, the detection method that virulence and genotype are measured synchronously is characterized in that P+Be used for the RT amplification, P-Be used for the order-checking of PCR product, the pcr amplification product size is 487bp.
5. newcastle disease virus according to claim 1 and vaccine virus difference diagnosis, the detection method that virulence and genotype are measured synchronously, it is characterized in that this specific information biology software comprises newcastle disease commonly used malicious vaccine F gene fragment 22-420 sequence library alive both at home and abroad, its title, feature and sequence are:
(a) La Sota:F gene cracking site aminoacid sequence is GRQGRL, weak poison, gene II type, nucleotide sequence are AAGAACCCAGCACCTATGATGCTGACTATCCGGGTTGCGCTGGTACTGAGTTGCAT CTGTCCGGCAAACTCCATTGATGGCAGGCCTCTTGCAGCTGCAGGAATTGTGGTTA CAGGAGACAAAGCCGTCAACATATACACCTCATCCCAGACAGGATCAATCATAGTT AAGCTCCTCCCGAATCTGCCCAAGGATAAGGAGGCATGTGCGAAAGCCCCCTTGGA TGCATACAACAGGACATTGACCACTTTGCTCACCCCCCTTGGTGACTCTATCCGTA GGATACAAGAGTCTGTGACTACATCTGGAGGGGGGAGACAGGGGCGCCTTATAGGC GCCATTATTGGCGGTGTGGCTCTTGGGGTTGCAACTGCCGCACAAATAACAGCGGC CGCAGCT
(b) Avinew:F gene cracking site aminoacid sequence is GRQGRL, weak poison, gene I type, nucleotide sequence are AGGATCCCAGTACCTCTTATGCTGACCGTCCGAGTCATGTTGGCACTGAGTTGCGT CTGTCCGACCAGCGCCCTTGATGGCAGGCCTCTTGCAGCTGCAGGGATTGTGGTAA CAGGAGACAAAGCAGTCAACATATACACCTCATCTCAGACAGGGTCAATCATAATC AAGTTACTCCCAAATATGCCCAAGGATAAAGAGGCGTGTGCAAAAGCCCCGTTGGA GGCATACAACAGGACATTGACTACTTTGCTCACCCCCCTTGGTGATTCTATCCGTA GGATACAAGAGTCTGTGACCACGTCCGGAGGAGGGAAACAGGGACGTCTTATAGGC GCCATTATCGGTGGTGTAGCTCTCGGGGTTGCAACCGCTGCACAGATAACAGCAGC CTCGGCT
(C) V.H.:F gene cracking site aminoacid sequence is GRQGRL, weak poison, gene I type, nucleotide sequence are AGGATCCCAGTACCTCTGATGCTGACCGTCCGATTTGTGCTGGCACTGAGTTGCAT CTGTCCGACTAGCTCCCTTGATGGCAGGCCTCTTGCAGCTGCAGGGATTGTGGTAA CAGGAGACAAAGCAGTCAACATATACACCTCATCTCAGACAGGGTCAATCATAGTC AAGTTACTCCCAAATATGCCCAAAGATAAAGAGGCGTGTGCAAAAGCCCCGTTGGA GGCGTACAACAGGACATTGACCACTTTGCTCACCCCCCTTGGTGATTCTATCCGTA GGATACAAGAGTCCGTGACCACATCTGGAGGAGGGAAACAAGGACGCCTTATAGGC GCCATTATCGGTGGTGCAGCTCTCGGGGTTGCAACCGCTGCACAGATAACAGCAGC CTCGGCT
(d) newcastle disease I system: F gene cracking site aminoacid sequence is RRQRRF, poison, gene III type, nucleotide sequence are AGGATCCCAGTACCTCTAATGCTGACCATACGGATCACGCTGGCACTGAGTTATGT CCGTCTGACAAGTTCTCTTGATGGCAGGCCTCTTGCAGCCGCAGGGATCGTGGTAA CAGGGGATAAAGCAGTTAACATATACACCTCATCCCAGACAGGGTCAATCATAGTC AAGTTACTCCCAAATATGCCCAAGGACAAAGAGGCATGTGCAAAAGCCCCATTGGA GGCTTACAACAGGACACTGACTACTTTGCTTACCCCCCTTGGTGATTCTATCCGCA GGATACAAGAGTCTGTGACTACATCCGGAGGAAGGAGACAGAGACGCTTTATAGGT GCCATTATTGGCAGTGTAGCTCTAGGGGTTGCAACAGCTGCACAGATAACGGCAGC CTCGGCT
6. newcastle disease virus according to claim 1 and vaccine virus difference diagnosis, the detection method that virulence and genotype are measured synchronously is characterized in that the threshold value of this specific information biology software differentiation newcastle disease virus and vaccine virus is:
(a) vaccine virus: with the few nucleotide of the highest standard newcastle disease living vaccine of homology variation be 0-4;
(b) doubtful vaccine virus: with the few nucleotide of the highest standard newcastle disease living vaccine of homology variation be 5-7;
(c) wild poison: with the few nucleotide of the highest standard newcastle disease living vaccine variation of homology greater than 7.
7. newcastle disease virus according to claim 1 and vaccine virus difference diagnosis, the detection method that virulence and genotype are measured synchronously, it is characterized in that this specific information biology software is by joining with standard Avian pneumo-encephalitis virus sequence homology connection, strain sequence to be measured is positioned, cut out the purpose fragment.
8. newcastle disease virus according to claim 1 and vaccine virus difference diagnosis, the detection method that virulence and genotype are measured synchronously, it is characterized in that this specific information biology software cutting F gene fragment 22-420, fragment 334-351, fragment 22-389 is respectively applied for the mensuration of nucleic acid variance, the judgement and the genotypic mensuration of peptide section virulence feature.
9. newcastle disease virus according to claim 1 and vaccine virus difference diagnosis, the detection method that virulence and genotype are measured synchronously, it is characterized in that this specific information biology software by setting the combination decision condition, solves vaccine virus and identifies the relation of judging contradiction with virulence.
10. newcastle disease virus according to claim 1 and vaccine virus difference diagnosis, the detection method that virulence and genotype are measured synchronously is characterized in that in the combination decision condition of the information biology software set that this is specific,
A) F gene cracking site sequence be in strong malicious sequence signature, and the virus to be measured that the nucleic acid variance is in the attenuated vaccine poison threshold range is accredited as doubtful vaccine virus, and is strong in the virulence;
B) F gene cracking site sequence can't be translated,, and the virus to be measured that the nucleic acid variance is in the attenuated vaccine poison threshold range is accredited as doubtful vaccine virus, virulence can't be measured;
C) the nucleic acid variance is in the virus to be measured in the poisoning vaccine virus threshold range, and no matter F gene cracking site sequence feature why all is accredited as vaccine virus, in the virulence;
D) other situation, the seedling poison is identified with the virulence result of determination and is carried out simple combination according to nucleic acid variance parameter and F gene cracking site sequence virulence parameter.
CN 200510060646 2005-09-05 2005-09-05 Method of synchronous distinguishing newcastle disease virus and vaccine virus and identifying virulence and genotype Pending CN1928117A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510060646 CN1928117A (en) 2005-09-05 2005-09-05 Method of synchronous distinguishing newcastle disease virus and vaccine virus and identifying virulence and genotype

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510060646 CN1928117A (en) 2005-09-05 2005-09-05 Method of synchronous distinguishing newcastle disease virus and vaccine virus and identifying virulence and genotype

Publications (1)

Publication Number Publication Date
CN1928117A true CN1928117A (en) 2007-03-14

Family

ID=37858248

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510060646 Pending CN1928117A (en) 2005-09-05 2005-09-05 Method of synchronous distinguishing newcastle disease virus and vaccine virus and identifying virulence and genotype

Country Status (1)

Country Link
CN (1) CN1928117A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114408B2 (en) * 2007-11-30 2012-02-14 Republic Of Korea (Management: Ministry Of Agriculture And Forestry, National Veterinary Research) Peptide fragments reacting specifically with antibodies against highly pathogenic newcastle disease virus and uses thereof
CN103374631A (en) * 2012-04-17 2013-10-30 中国农业大学 RT-PCR (reverse transcription-polymerase chain reaction) method for identifying epidemic strains and vaccine strains of newcastle disease virus (NDV)
CN104313183A (en) * 2014-10-25 2015-01-28 咸阳职业技术学院 Composite nested polymerase chain reaction diagnostic kit capable of identifying Lasota vaccine strains and gene type VII epidemic strains of Newcastle diseases (ND)
CN105525041A (en) * 2016-01-29 2016-04-27 山东省农业科学院畜牧兽医研究所 Reverse transcription fluorogenic quantitative PCR primer for rapidly identifying high virulent Newcastle disease virus (NDV) strain and identification method
CN113106171A (en) * 2021-03-18 2021-07-13 中国计量大学 Newcastle disease virus vaccine strain identification and mutation detection method based on nanopore sequencing platform and application

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114408B2 (en) * 2007-11-30 2012-02-14 Republic Of Korea (Management: Ministry Of Agriculture And Forestry, National Veterinary Research) Peptide fragments reacting specifically with antibodies against highly pathogenic newcastle disease virus and uses thereof
CN103374631A (en) * 2012-04-17 2013-10-30 中国农业大学 RT-PCR (reverse transcription-polymerase chain reaction) method for identifying epidemic strains and vaccine strains of newcastle disease virus (NDV)
CN104313183A (en) * 2014-10-25 2015-01-28 咸阳职业技术学院 Composite nested polymerase chain reaction diagnostic kit capable of identifying Lasota vaccine strains and gene type VII epidemic strains of Newcastle diseases (ND)
CN105525041A (en) * 2016-01-29 2016-04-27 山东省农业科学院畜牧兽医研究所 Reverse transcription fluorogenic quantitative PCR primer for rapidly identifying high virulent Newcastle disease virus (NDV) strain and identification method
CN113106171A (en) * 2021-03-18 2021-07-13 中国计量大学 Newcastle disease virus vaccine strain identification and mutation detection method based on nanopore sequencing platform and application

Similar Documents

Publication Publication Date Title
CN1814805A (en) H5, H7, H9 subtype auian flu virus real-time fluo rescent quantixative PCR detecting method
Selim et al. Molecular characterization of full fusion protein (F) of Newcastle disease virus genotype VIId isolated from Egypt during 2012-2016
CN1274757A (en) Oligonucleotide primer for effective detection of hepatitis C virus (HCV) and its use
CN1928117A (en) Method of synchronous distinguishing newcastle disease virus and vaccine virus and identifying virulence and genotype
CN1944673A (en) Fluorescent quantitative PCR detecting method for hepatitis B virus and special reagent kit
Venter Molecular differentiation and pathogenicity of Aviadenoviruses isolated during an outbreak of inclusion body hepatitis in South Africa
Knoetze et al. Two genotypes of infectious bronchitis virus are responsible for serological variation in KwaZulu-Natal poultry flocks prior to 2012
CN1164767C (en) Fluorescent quantitative PCR kit for rapid and quantitative detecting hog choleravirus and hog cholera lapinized vaccine and its use
CN101045943A (en) Process of PCR detecting salmonella with added amplifying internal standard
Zhang et al. Molecular characterization of chicken anemia virus in Guangxi Province, southern China, from 2018 to 2020
CN1308461C (en) Fluorescence quantitative PCR kit for detecting virus of aftosa and application
CN1724686A (en) Target sequence used for detecting mycoplasma pnoumoniae and reagent box
CN1831139A (en) Molecular biological quantitative detecting method for pathogenicity paratypic hemolytic vibrio in aquatic products
CN1827775A (en) Nucleotide sequence for detecting newcastle disease virus, kit and detection method thereof
Hasırcıoglu et al. Molecular characterization of carnivore protoparvovirus strains circulating in cats in Turkey
CN1690220A (en) Method and kit for testing chain reaction of reverse transcription polymerase of avian influenza virus
CN1269966C (en) Method for the amplification and detection of HBV DNA using a transcription based amplification
CN1754959A (en) Preparation process and application of genetic engineering subunit vaccine of infectious bursal disease
CN1188530C (en) Gene detection kit and detection method for SARS virus
CN100335636C (en) Thioredoxin gene of Schistosoma japonicum (Chinese Mainland Strain) and its cloning expression method and application
CN1556216A (en) Detecting method of blue tongue virus and reagent box
CN1683564A (en) Method for detecting bird flu and newcastle disease virus by composite quantitative polyase chain reaction
CN100339488C (en) Detection method of hepatitis B virus genome drug resistance mutation
CN1522760A (en) Bivalent gene engineering vaccine of fowl infectious bursal disease and pasteurellosis
Vidović et al. Molecular characterization of infectious bronchitis virus strains isolated from vaccinated flocks in Serbia and their comparison with the isolated strains from neighboring countries

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication